GOLDMAN SACHS GROUP INC - ALDER BIOPHARMACEUTICALS INC ownership

ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 135 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 2.83 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ALDER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$35,075,000
-22.6%
1,859,760
-51.7%
0.01%
-23.1%
Q2 2019$45,307,000
+0.9%
3,849,394
+17.0%
0.01%
-7.1%
Q1 2019$44,899,000
+58.6%
3,289,275
+19.1%
0.01%
+55.6%
Q4 2018$28,312,000
+42.9%
2,762,172
+132.2%
0.01%
+80.0%
Q3 2018$19,810,000
-4.1%
1,189,776
-9.0%
0.01%
-16.7%
Q2 2018$20,659,000
-4.0%
1,307,520
-22.9%
0.01%0.0%
Q1 2018$21,528,000
+13.1%
1,695,087
+2.0%
0.01%
+20.0%
Q4 2017$19,030,000
+2.4%
1,661,997
+9.6%
0.01%0.0%
Q3 2017$18,577,000
+125.8%
1,516,494
+111.1%
0.01%
+150.0%
Q2 2017$8,226,000
-40.9%
718,389
+7.4%
0.00%
-50.0%
Q1 2017$13,917,000
-1.3%
669,085
-1.3%
0.00%0.0%
Q4 2016$14,106,000
-56.3%
678,180
-31.2%
0.00%
-60.0%
Q3 2016$32,286,000
-2.0%
985,207
-25.3%
0.01%
-9.1%
Q2 2016$32,929,000
+136.8%
1,318,757
+132.3%
0.01%
+175.0%
Q1 2016$13,907,000
-25.1%
567,804
+1.0%
0.00%
-33.3%
Q4 2015$18,566,000
+48.7%
562,102
+47.5%
0.01%
+50.0%
Q3 2015$12,483,000
-25.7%
381,026
+20.1%
0.00%
-20.0%
Q2 2015$16,811,000
+55.5%
317,373
-15.3%
0.01%
+66.7%
Q1 2015$10,813,000
+75.1%
374,695
+76.5%
0.00%
+50.0%
Q4 2014$6,177,000212,3490.00%
Other shareholders
ALDER BIOPHARMACEUTICALS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Novo Holdings A/S 3,201,183$40,591,0003.96%
Cormorant Asset Management, LP 150,000$1,902,0000.39%
PFM Health Sciences, LP 1,034,030$13,112,0000.30%
Partner Investment Management, L.P. 23,660$300,0000.11%
PointState Capital LP 375,000$4,755,0000.09%
Spark Investment Management LLC 38,400$486,0000.07%
SECTORAL ASSET MANAGEMENT INC 89,300$1,132,0000.05%
DRIEHAUS CAPITAL MANAGEMENT LLC 95,722$1,214,0000.05%
CADIAN CAPITAL MANAGEMENT, LP 120,000$1,522,0000.04%
Nicholas Investment Partners, LP 49,341$626,0000.04%
View complete list of ALDER BIOPHARMACEUTICALS INC shareholders